Teriflunomide

Brand name: Aubagio

Rank #127 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$131.9M

Total Cost

Share:

18,010

Total Claims

$131.9M

Total Cost

757

Prescribers

$7,326

Cost per Claim

588

Beneficiaries

19,677

30-Day Fills

$174K

Avg Cost/Provider

24

Avg Claims/Provider

Share of Medicare Part D Spending

0.05%

of total Medicare Part D spending

$131.9M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $131.9M total

🔎 Data Overview

💰

At $7,326 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $174,306 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

👤

Average cost of $224,404 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Teriflunomide

#ProviderSpecialtyLocationClaimsCost
1Anna CluskeyPhysician AssistantMilwaukee, WI291$2.8M
2Donald NegroskiNeurologySarasota, FL123$1.3M
3David MeyerNeurologyWinston-Salem, NC121$1.2M
4Aimee BorazanciNeurologyPhoenix, AZ114$1.1M
5Allen GerberNeurologyFishkill, NY111$1.1M
6Harold MosesNeurologyNashville, TN74$963K
7Christopher SheppardNeurologyUniontown, OH97$963K
8Donald BaroneNeurologyCamden, NJ75$874K
9Brian SteingoNeurologyBoca Raton, FL80$869K
10Stacy DonlonNeurologyTacoma, WA79$785K
11Renee StewartNurse PractitionerOmaha, NE84$774K
12Mary Ann PiconeNeurologyTeaneck, NJ71$765K
13Randall TrudellNeurologyKnoxville, TN76$755K
14Neil JouvenatPhysician AssistantOmaha, NE87$729K
15Mark CascioneNeurologyTampa, FL71$714K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology